Diphtheria News and Research

RSS

Diphtheria is a disease caused by a bacterium, Corynebacterium diphtheriae, that usually affects the tonsils, throat, nose and/or skin. It is passed from person to person by droplet transmission, usually by breathing in diphtheria bacteria after an infected person has coughed or sneezed. Although diphtheria disease is rare in the U.S., it appears that C diphtheriae continues to circulate in areas of the country with previously endemic diphtheria. Diphtheria also occurs in many other parts of the world.

Study describes health outcomes following simultaneous vaccination with monovalent primary series COVID-19 vaccines

Researchers described simultaneous vaccination with primary series SARS-CoV-2 vaccines

19 Jun 2023

Study reveals factors impacting pertussis antibody half-lives in infants, sheds light on preterm infants' resilience

Researchers compared two methods of half-life estimation to evaluate the half-life of maternal antibodies.

9 Jun 2023

Vaccination coverage drops in U.S. schools, raising concerns of outbreaks

Research highlights the decline in national coverage of state-required vaccines among kindergarten students during the 2020-2021 and 2021-2022 school years. Despite a low exemption rate, vaccination coverage decreased further in the latter year, indicating ongoing COVID-19 disruptions and emphasizing the need for increased follow-up with under-vaccinated students to protect against vaccine-preventable diseases.

22 May 2023

Advancing the development of vaccines through recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about current developments in the field of vaccine development through recombinant techniques.

From Sino Biological Inc. 4 May 2023

A high proportion of adults in Europe do not have protective antibody concentrations against diphtheria

Researchers conducted a retrospective analysis of seroprotection against tetanus and diphtheria among residents in Austria.

1 May 2023

Adherence to national guidelines for childhood vaccination on the rise, study shows

The percentage of children under 19 months who received all recommended vaccines on-time steadily improved from 22.5% in 2011 to 34.9% in 2020, according to a new national study.

28 Apr 2023

New DCFHP-alum COVID-19 vaccine candidate shows durable, broad-spectrum protection in non-human primates

The newly developed DCFHP-alum COVID-19 vaccine candidate is affordable and effective for mass vaccination.

18 Apr 2023

Low vaccine coverage fuels recurrence of diphtheria in Nigeria

Low vaccine coverage and weak infrastructure have fuelled a recurrence of diphtheria in Nigeria, especially in rural areas beset by poor access to healthcare services, public health experts say.

28 Mar 2023

Montana considers new wave of legislation to loosen vaccination rules

When Deb Horning's youngest daughter was 5, she got her measles, mumps, and rubella shot like many other kindergartners. But unlike many other moms, Horning had to stay away from her daughter for a week after the shot.

10 Mar 2023

A technicality could keep RSV shots from kids in need

After more than five decades of trying, the drug industry is on the verge of providing effective immunizations against the respiratory syncytial virus, which has put an estimated 90,000 U.S. infants and small children in the hospital since the start of October.

6 Feb 2023

Study shows cutaneous touch neuronal cells to be critical for sexual receptiveness

Researchers studied the social relevance of G protein-coupled receptor (GPCR) Mrgprb4-lineage touch neurons in sexual touch and receptivity.

25 Jan 2023

State-of-the-art Biocontainment Unit opened at MedStar Washington Hospital Center

MedStar Washington Hospital Center has opened a state-of-the-art Biocontainment Unit that will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly infectious diseases.

19 Jan 2023

Oxford's Ebola vaccine candidate manufactured and shipped to Uganda in just 80 days

Oxford's Ebola vaccine candidate has been shipped to Uganda, just 80 days after WHO declared a Sudan ebolavirus outbreak, having been manufactured by its partner the Serum Institute of India and working in close partnership with WHO.

5 Jan 2023

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Nearly three years into the pandemic, many of us now carry antibodies against the virus-;due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment.

6 Dec 2022

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Researchers investigated passive immunization of the fetus and neonates by evaluating the antibody responses elicited by primary and booster doses of maternal SARS-CoV-2 vaccination.

2 Dec 2022

Impact of an individually tailored educational application on vaccine attitudes of pregnant women and mothers

Researchers evaluated the impact of MomsTalkShots, a personalized application, on maternal attitudes toward vaccinations.

29 Nov 2022

Is placental antibody transfer after COVID-19 vaccination different from that after SARS-CoV-2 infection in pregnant individuals?

Researchers investigated the placental transfer ratios of anti-SARS-CoV-2 antibodies in pregnant females.

11 Nov 2022

25 years on, varicella vaccination reports impressive success in the USA

New research suggests that 25 years on, varicella vaccination continues to report impressive success in the USA.

26 Oct 2022

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, primarily causes mild to moderate upper-respiratory tract illness. However, some individuals with COVID-19 develop severe infections and require hospital admission.

27 Sep 2022

Study paves the way for new therapies, vaccines that lead to stronger immunity against Covid-19

Why do some people become seriously ill with Covid-19, while others have no symptoms at all? The answer may lie in the proteins our immune system has previously been exposed to.

23 Sep 2022